Abstract: The disclosure relates to the discovery that systemic administration of an antibody that binds to PECAM-1 increases body weight while suppressing the metastatic spread of a wide variety of different tumor types which are typically fatal in humans.
Type:
Application
Filed:
September 27, 2011
Publication date:
March 29, 2012
Applicant:
Sutter West Bay Hospitals D/B/A California Pacific Medical Center